EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges

Victor Ayodele Aliyu iD, Olalekan Chris Akinsulie iD, Babatunde Ibrahim Olowu iD, Ibrahim Idris iD, Favour Akinfemi Ajibade iD, Pius I Babawale iD, Oluwawemimo Adebowale iD, Charles Egede Ugwu iD, Chizaram Blessing Ukauwa iD, Onyedikachi Emmanuel Itumo, Peter Arinze Oge iD, Sammuel Shahzad and 7 more

Pathogens · 2026-07-28 · 15 (8) · 800

DOI: 10.3390/pathogens15080800 ↗

At a glance

Übersichtsarbeit in Pathogens, published online on 2026-07-28. Written by Victor Ayodele Aliyu and 18 co-authors. Institution: School of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA. Major MEDLINE topics: Oncogenic Viruses, Coinfection, Neoplasms, Tumor Virus Infections. 314 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Oncogenic viruses contribute to approximately 20% of human cancers globally, with their impact falling disproportionately on populations in Sub-Saharan Africa. In this region, cervical cancer, hepatocellular carcinoma, endemic Burkitt lymphoma, and Kaposi sarcoma represent major causes of cancer-related morbidity and mortality, driven by persistent infection with human papillomavirus (HPV), hepatitis B and C viruses (HBV/HCV), Epstein–Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV), and human T-lymphotropic virus-1 (HTLV-1). This review synthesizes current insights into the immunological mechanisms that underpin viral carcinogenesis in Africa, emphasizing how defective viral clearance, chronic immune activation, and immune evasion arise from the convergence of region-specific co-infections, host genetic diversity, and environmental exposures. We examine the mechanistic roles of HIV-associated CD4+ T cell depletion, malaria-induced perturbation of antiviral T cell immunity, helminth-driven T helper 2 polarization, and tuberculosis-associated inflammatory signaling in promoting viral persistence and malignant transformation. In addition, the influence of the extensive diversity of African human leukocyte antigens (HLA) and cytokine gene polymorphisms on antiviral immune responses and cancer susceptibility was discussed. We also assessed how virus-associated tumors establish profoundly immunosuppressive microenvironments characterized by impaired antigen presentation and the dominance of immune checkpoint pathways. Finally, we examined how gaps in vaccination, screening, and diagnostic capacity intersect with immunological vulnerability across Africa, contributing to the burden of infection-associated cancers. These challenges position Africa as a critical setting for developing targeted, genotype-inclusive public health interventions and reducing global cancer disparities through advances in immunoprevention and immunotherapy.

Subjects

MeSH terms (MEDLINE)

Oncogenic VirusesCoinfectionNeoplasmsTumor Virus InfectionsHumansPublic HealthAfricaAnimals

Author keywords

Epstein–Barr virus (EBV)hepatitis B virus (HBV)human papillomavirus (HPV)sub-Saharan Africaviral oncogenesis

Authors and institutions

  • School of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA.
  • Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA.
  • School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA.
  • Department of Microbiology and Molecular Genetics, The Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405, USA.
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Barton Rouge, LA 70803, USA.
  • Department of Veterinary Public Health and Preventive Medicine, College of Veterinary Medicine, Federal University of Agriculture Abeokuta, Abeokuta 110124, Ogun State, Nigeria.

ORCID profiles: Victor Ayodele Aliyu, Olalekan Chris Akinsulie, Babatunde Ibrahim Olowu, Ibrahim Idris, Favour Akinfemi Ajibade, Pius I Babawale, Oluwawemimo Adebowale, Charles Egede Ugwu, Chizaram Blessing Ukauwa, Peter Arinze Oge, Olamilekan Gabriel Banwo

Cite

APA

Aliyu, V. A., Akinsulie, O. C., Olowu, B. I., Idris, I., Ajibade, F. A., Babawale, P. I., Adebowale, O., Ugwu, C. E., Ukauwa, C. B., Itumo, O. E., Oge, P. A., Shahzad, S., Chukwu, C. L., Ayandokun, T. F., Aliyu, J. T., Aliyu, P. K., Akinsulie, J. M., Adeyemi, M. I., & Banwo, O. G. (2026). Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges. Pathogens, 15(8), 800. https://doi.org/10.3390/pathogens15080800

Vancouver

Aliyu VA, Akinsulie OC, Olowu BI, Idris I, Ajibade FA, Babawale PI, et al. Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges. Pathogens. 2026;15(8):800. doi:10.3390/pathogens15080800

BibTeX
@article{Aliyu2026,
  author = {Aliyu, Victor Ayodele and Akinsulie, Olalekan Chris and Olowu, Babatunde Ibrahim and Idris, Ibrahim and Ajibade, Favour Akinfemi and Babawale, Pius I and Adebowale, Oluwawemimo and Ugwu, Charles Egede and Ukauwa, Chizaram Blessing and Itumo, Onyedikachi Emmanuel and Oge, Peter Arinze and Shahzad, Sammuel and Chukwu, Chizobam Lilian and Ayandokun, Toyin Florence and Aliyu, Joy Taiye and Aliyu, Peace Kehinde and Akinsulie, Jesuferanmi Mary and Adeyemi, Muhammad Ipoola and Banwo, Olamilekan Gabriel},
  title = {Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {800},
  doi = {10.3390/pathogens15080800}
}
Start for free →